Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Retatrutide is a synthetic triple receptor agonist activating GLP-1, GIP, and glucagon receptors simultaneously, studied as a next-generation metabolic research compound
Sustainable weight loss: Regular use supports steady, long-term weight loss when taken with a reduced-calorie diet plan and physical activity
GLP-1 receptor agonists have a well-characterized side effect profile that differs substantially from cancer risk
The more serious side effects include gallbladder disease and biliary tract disease including cholelithiasis -gall stones, and cholecystitis-inflammation of the gallbladder
US$ 29.79
US$ 25.51
US$ 24.77
US$ 29.00
